Double-Blind Assessment of Potential Pergolide-Induced Cardiotoxicity
Neurol 36:993-995, Kurlan,R.,et al, 1986
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984
Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth Hormone
NEJM 309:704-709, Kleinberg,D.K.,et al, 1983
Reduction in Size of Prolactin-secreting Tumours in Men Treated with Pergolide
BMJ 285:465-467, Kendall-Taylor,P.,et al, 1982
Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981